112 related articles for article (PubMed ID: 20682177)
41. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
42. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
[TBL] [Abstract][Full Text] [Related]
43. Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines.
Yang M; Loda M; Sytkowski AJ
Cancer Res; 1998 Aug; 58(16):3732-5. PubMed ID: 9721886
[TBL] [Abstract][Full Text] [Related]
44. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
45. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
[TBL] [Abstract][Full Text] [Related]
46. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
[TBL] [Abstract][Full Text] [Related]
47. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
[TBL] [Abstract][Full Text] [Related]
48. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
49. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
50. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
51. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
[TBL] [Abstract][Full Text] [Related]
52. [Pathological basis for elevation of serum prostate specific antigen].
Xia TL; Deng FM; Feng T
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):306-8, 327. PubMed ID: 7525028
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
Kuasne H; Rodrigues IS; Fuganti PE; Losi-Guembarovski R; Ito K; Kishima MO; Rodrigues MA; Rogatto SR; Santos RM; Cólus IM
Cancer Invest; 2010 Nov; 28(9):917-24. PubMed ID: 20632874
[TBL] [Abstract][Full Text] [Related]
54. Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy.
Ghafouri-Fard S; Modarressi MH
Immunotherapy; 2012 Jan; 4(1):59-75. PubMed ID: 22150001
[TBL] [Abstract][Full Text] [Related]
55. Seminal fluid: a useful source of prostate cancer biomarkers?
Roberts MJ; Richards RS; Gardiner RA; Selth LA
Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
[No Abstract] [Full Text] [Related]
56. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Sep; 9(12):1019-1034. PubMed ID: 28971747
[TBL] [Abstract][Full Text] [Related]
57. New virus linked to prostate cancer.
Hampton T
JAMA; 2006 Apr; 295(13):1503. PubMed ID: 16595746
[No Abstract] [Full Text] [Related]
58. Genetic alterations in prostate cancer.
Chin JL; Reiter RE
Curr Urol Rep; 2004 Jun; 5(3):157-65. PubMed ID: 15161563
[TBL] [Abstract][Full Text] [Related]
59. Re: The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein.
Atala A
J Urol; 2011 Dec; 186(6):2494-5. PubMed ID: 22078626
[No Abstract] [Full Text] [Related]
60. GSE is a maternal factor involved in active DNA demethylation in zygotes.
Hatanaka Y; Shimizu N; Nishikawa S; Tokoro M; Shin SW; Nishihara T; Amano T; Anzai M; Kato H; Mitani T; Hosoi Y; Kishigami S; Matsumoto K
PLoS One; 2013; 8(4):e60205. PubMed ID: 23560077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]